DMRTA2: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: DMRTA2

NCBI ID: G63950

DMRTA2

DMRTA2: A Potential Drug Target for Cancer and Neurodegenerative Diseases

DMRTA2 (DMTA2_HUMAN), a protein expressed in human tissues, has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other proteins have been extensively studied, providing insights into its potential role in human health and disease.

DMRTAs are a family of proteins that belong to the TPR (transmembrane protein) superfamily. They are characterized by a conserved catalytic core and a unique N-terminal region that contains a putative transmembrane domain and a unique C-terminal region that is involved in protein -protein interactions. DMRTAs are involved in various physiological processes, including cell signaling, protein-protein interactions, and intracellular signaling pathways.

DMRTA2 is a 21-kDa protein that is expressed in various human tissues, including brain, heart, liver, and pancreas. It is involved in several cellular processes, including cell signaling, cell adhesion, and chromatin structure. The protein has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

DMRTA2 is a potential drug target for cancer, due to its involvement in cell signaling pathways that are often disrupted in cancer cells. For example, DMRTA2 has been shown to be involved in the TGF-灏? pathway, a well-established cancer-promoting pathway that plays a role in the development and progression of many types of cancer.

DMRTA2 has also been shown to be involved in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to be caused by disruptions in the normal functioning of neuronal cells. The involvement of DMRTA2 in these diseases suggests that it may be a valuable target for new therapeutic approaches.

DMRTA2 has also been shown to be involved in autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. These conditions are characterized by the immune system attacking the body's own tissues, leading to inflammation and joint damage. The involvement of DMRTA2 in these disorders suggests that it may be a potential target for new therapeutic approaches.

In conclusion, DMRTA2 is a protein that has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its functions and interactions with other proteins have provided insights into its potential role in human health and disease. Further research is needed to fully understand the role of DMRTA2 in these conditions and to develop new therapeutic approaches.

Protein Name: DMRT Like Family A2

Functions: May be involved in sexual development

The "DMRTA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DMRTA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets